Union Minister of Chemicals & Fertilizers and Health & Family Welfare, Shri Jagat Prakash Nadda inaugurates the week long celebrations of Jan Aushadhi Diwas, 2025

by with No Comment Health and CommunityLatest Updates

Union Minister of Chemicals & Fertilizers and Health & Family Welfare, Shri Jagat Prakash Nadda inaugurated the weeklong celebrations of Jan Aushadhi Diwas, 2025 by flagging off the Rath (Chariot) and 10 other vehicles carrying the information about Pradhan Mantri Bhartiya Janaushadhi Pariyojana from Nirman Bhawan today. Union Minister of State for Chemicals & Fertilizers, Ms. Anupriya Patel and Secretary, Department of Pharmaceuticals, Shri Amit Agrawal were also present on the occasion.

Addressing the gathering during the flag off ceremony Shri Jagat Prakash Nadda urged the citizens of the country to participate in these programs for wider awareness about this noble project of the Government so that a Jan-Andolan is created for Jan-Aushadhi.

Ms. Anupriya Patel also addressed the gathering and gave a brief about seven days week long programs to be held across the country for celebration of 7th Jan Aushadhi Diwas.

At the initiative of the Prime Minister Shri Narendra Modi, the 7th of March is celebrated every year as “Jan Aushadhi Diwas” with a view to enhance awareness about the scheme and promote generic medicines. As in earlier years, week-long events have been planned at various locations across the country from the 1st to the 7th of March 2025. The vehicles that have been flagged off today will disseminate the information about PMBJP in the National Capital Region (NCR).

With an objective of making quality generic medicines available at affordable prices to all, Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) was launched by the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India. Under this scheme, dedicated outlets known as Jan Aushadhi Kendras (JAKs) are opened to provide generic medicines.

As on 28.02.2025, 15000 Jan Aushadhi Kendras (JAKs) have been opened across the country. Product basket of PMBJP comprises 2047 drugs and 300 surgical equipment which are sold at retail shops at 50% to 80% cheaper than branded medicines.

Under PMBJP, the government has set a target to open 25000 JAKs by 31st March, 2027 across the country. The target of opening 15000 JAKs by March, 2025 has already been achieved by PMBI on 31.01.2025.

In order to cover large category of medicines, 29 Major Therapeutic Groups like Antibiotics & Anti-infectives, Anti-Cancer, Anti-Diabetics, Cardiovascular Drugs, Analgesics and Antipyretic, Anti-Allergic, Gastro-Intestinal Agents, Vitamins & Minerals, Food supplements/Nutraceuticals, Topical Medicines etc have been covered in PMBJP basket. Further, 300 Surgical Equipment & Consumable like Masks, Orthopedic Rehabilitation Products, Surgical Dressings, Syringes & Needles, Sanitary Napkins, Sutures, Diapers, Rubber Gloves, Oximeter, Rapid Antigen Test Kit, etc have also been covered under PMBJP basket.

In the financial year i.e., 2023-24, PMBJP has made sales of Rs. 1470 Crore (at MRP) which has led to savings of approximately Rs. 7350 Cr. to the citizens. In the current financial year i.e., 2024-25, PMBJP has made sales of Rs. 1760 Crore (at MRP) till 28.02.2025. In the last 10 years, the no. of Kendras have increased by 180 times and the sales have also increased more than 200 times. In all, during the past 10 years, total savings of approximately Rs. 30,000 crores for the citizens have been possible due to this noble scheme.

Union Health Minister Shri J P Nadda reviews Regulation of Drugs, Cosmetics and Medical Devices

by Health and CommunityLatest Updates

“For India to become the global leader in drugs regulation to match our global reputation of ‘Pharmacy of the World’, we need to have world class regulatory framework matching our scale of operations and international expectations”. This was stated by Union Health Minister Shri J P Nadda, as he reviewed the regulation of drugs, cosmetics and medical devices, here today. Union Health Secretary Shri Apurva Chandra, Drugs Controller General of India (DCGI) Dr Rajeev Singh Raghuvanshi and senior officers of Central Drugs Standard Control Organization (CDSCO) and Union Health Ministry were present at the high level review meeting.

Highlighting the global position of India as the leading producer and exporter of drugs, Shri J P Nadda stressed on CDSCO to draw a roadmap with timelines of achieving global standards in its mandated activities. He stated that the upscaling needs to be systems-based focusing on highest standards of uniformity, technical upgradation and futuristic approach. For export of drugs and pharmaceuticals, the system should be designed for proper intervention to maintain the quality of drugs being exported, he emphasized.

Shri Nadda underscored the importance of transparency in the working of CDSCO. He stated that “In order to achieve global standards, our focus needs to be on transparency of procedures at CDCSO and within the drugs and medical devices industry”. Both the Drugs Regulatory body and the industry should work on highest principles of transparency to ensure that the products manufactured and sold by India meet the highest indices of global quality standards, he said.

The Union Health Minister stated that it is important for CDSCO to be in continuous dialogue with the drugs and medical devices industry to understand their issues and support them to fulfill the quality expectations and standards of CDSCO. “Our focus should be on developing mechanisms that ensure easy of doing business for the drugs industry within the regulatory requirements. For this, CDSCO needs to be a user-friendly organization with state-of-the-art facilities matching global standards”, he stated. 

On the topic of Micro, Small & Medium Enterprises (MSME) sector in drugs manufacturing and the issues faced by the small scale industries to meet quality standards, the Union Health Minister “Let us understand the issues faced by MSME sector and support them to strengthen their capacity and quality of products on the one hand, and encourage them to meet the regulatory requirements on the other.”

Shri Nadda was briefed about the mandated activities of CDSCO, its achievements, future plans and various issues and challenges faced by CDSCO. The Minister was also updated on the progress of the Scheme for strengthening state drug regulatory system with a budget of Rs.850 crores which was launched in 2016 during his earlier tenure.

The Union Minister was briefed on the roles and responsibilities of the central and state drugs regulatory bodies, and some of the challenges faced in alignment between them. Noting that the States are integral part of our regulatory value chain, Shri Nadda underscored the importance of working in tandem with the States so as to enhance their skills and capacities, and also encourage them to align with quality standards of the Central Government. “This is especially important in view of upgradation of Good Manufacturing Practices to global level embarked upon by CDSCO”, he added.